Grace Therapeutics, Inc 10-Q for FY2023 Q2
Grace Therapeutics, Inc. (GRCE)
10-Q
2022-11-14
For: 2022-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Grace Therapeutics, Inc filed this 10-Q on November 14, 2022, covering the quarter ended September 30, 2022 (FY2023 Q2).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $4.93M
- compared with net income of $981K a year earlier
- Diluted EPS
- -$0.11
- compared with -$0.03 a year earlier